Print Friendly, PDF & Email

NCT/Study#

NA /

SALA-002-EW16

Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) With and Without Topotecan and Cyclophosphamide in Patients With Relapsed or Refractory Ewing Sarcoma and Select Sarcomas

DISEASE GROUP:

Skin and Soft Tissue

current phase:

NA

STUDY STATUS:

Active

Location:

Hackensack, NJ

For More information:

Call 201-518-3587